Partnering With Us
At Noven, we believe collaboration drives scientific discovery and improves patient outcomes.
Noven and our parent company, Hisamitsu, jointly seek partnership opportunities that are aligned with our core areas of expertise.
Therapeutic & Drug Delivery Modalities
We are actively seeking partnerships across a variety of modalities including:
|
Ways to Partner
In-licensing,
Out-Licensing
& Acquisitions
_______________
Noven focuses on mature brands and ready to commercialize assets within the US:
- ADHD & Comorbid Conditions
- Women’s Health
- Any formulation (oral, injectable, topical, transdermal)
Hisamitsu extends these opportunities globally, covering:
- Pain Management, Orthopedic, Women’s Health, Cancer Supportive Care, Dermatology
- Any stage of development (early-stage to commercialized)
- Any formulation
Transdermal Drug
Development
& Innovation
_______________
Noven and Hisamitsu are actively working to advance transdermal drug delivery technologies. We seek partners for:
- Collaborative development of new TDDS solutions utilizing our formulation expertise
- Joint research and product development initiatives to enhance transdermal efficacy and delivery systems
Why Partner with Noven & Hisamitsu?
-
-
-
-
-
- Decades of expertise in transdermal drug development & manufacturing
- Access to global commercialization channels through Hisamitsu
- Strong track record in regulatory approvals and market expansion
-
-
-
-
Let’s Connect
| Interested in exploring a partnership? Contact our business development team at busdev@noven.com |